TABLE 4.
Efficacy by treatment regimen at day 42
| Outcome | No. (%) of women |
|||
|---|---|---|---|---|
| 3 days |
5 days |
|||
| Pregnant | Nonpregnant | Pregnant | Nonpregnant | |
| Allocated | 24 | 24 | 24 | 24 |
| Deliveries before day 42 | 2 | 4 | ||
| Lost to follow-up | 0 | 0 | 0 | 1 (4.2) |
| Evaluable | 22 (91.7) | 24 | 20 (83.3) | 23 (95.8) |
| Early treatment failure | 0 | 0 | 0 | 0 |
| Late clinical failure | 0 | 0 | 1 (5.0) | 0 |
| Late parasitological failure | 2 (9.1) | 3 (12.5) | 1 (5.0) | 1 (4.3) |
| Adequate clinical and parasitological response (ACPR) | 20 (90.9) | 21 (87.5) | 18 (90.0) | 22 (95.7) |
| New falciparum infection | 0 | 3 | 2 | 1 |
| Recrudescence (P. falciparum) | 0 | 0 | 0 | 0 |
| Undetermined PCR result | 2 | 0 | 0 | 0 |
| ACPR PCR corrected | 20 (100) | 24 (100) | 20 (100) | 23 (100) |